Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Allergy Therapeutics plc    AGY   GB00B02LCQ05

ALLERGY THERAPEUTICS PLC

(AGY)
  Report
Delayed Quote. Delayed London Stock Exchange - 01/26 04:18:28 am
19.4 GBX   -0.26%
01/14ALLERGY THERAPEUTICS : Half Year Trading Update 2021 and Notice of Results
AQ
2020ALLERGY THERAPEUTICS : 2020 AGM Poll Vote Results
PU
2020ALLERGY THERAPEUTICS : Notice of Meeting
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization1 16889,189,1125--
Entreprise Value (EV)1 15564,155,995,1106107
P/E ratio -22,2x26,9x13,3x-26,8x-20,5x-15,0x
Yield ------
Capitalization / Revenue 2,46x1,21x1,14x1,49x1,41x1,34x
EV / Revenue 2,27x0,87x0,71x1,14x1,20x1,15x
EV / EBITDA -33,0x9,88x4,57x-224x-138x-76,2x
Price to Book 7,32x2,37x2,04x3,30x3,74x4,74x
Nbr of stocks (in thousands) 594 118636 169636 169640 792--
Reference price (GBP) 0,280,140,140,190,190,19
Last update 09/26/201809/25/201909/23/202001/13/202101/13/202101/13/2021
1 GBP in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales1 68,373,778,283,488,293,1
EBITDA1 -4,716,4812,2-0,42-0,77-1,40
Operating profit (EBIT)1 -6,734,398,31-3,66-4,33-5,50
Operating Margin -9,85%5,96%10,6%-4,39%-4,90%-5,91%
Pre-Tax Profit (EBT)1 -6,904,298,07-4,00-4,75-6,60
Net income1 -7,533,477,06-4,55-6,01-8,10
Net margin -11,0%4,70%9,03%-5,45%-6,82%-8,70%
EPS2 -0,010,010,01-0,01-0,01-0,01
Dividend per Share2 ------
Last update 09/26/201809/25/201909/23/202001/22/202101/22/2021-
1 GBP in Million
2 GBP
Estimates
Balance Sheet Analysis
Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 12,525,033,229,518,918,0
Leverage (Debt / EBITDA) 2,65x-3,86x-2,72x69,7x24,6x12,9x
Free Cash Flow1 -5,812,799,75-6,10-6,71-4,50
ROE (Net Profit / Equities) -28,4%11,4%17,4%-11,2%-12,6%-27,1%
Shareholders' equity1 26,530,340,740,647,729,9
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 0,040,060,070,060,050,04
Cash Flow per Share2 -0,010,010,02-0,01-0,01-
Capex1 2,012,812,262,522,942,10
Capex / Sales 2,93%3,81%2,89%3,02%3,33%2,26%
Last update 09/26/201809/25/201909/23/202001/22/202101/22/202101/13/2021
1 GBP in Million
2 GBP
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (GBP)
124 634 075
Capitalization (USD)
170 158 200
Net sales (GBP)
78 204 000
Net sales (USD)
106 474 746
Free-Float
13,8%
Free-Float capitalization (GBP)
17 171 829
Free-Float capitalization (USD)
23 444 050
Avg. Exchange 20 sessions (GBP)
11 311 407
Avg. Exchange 20 sessions (USD)
15 400 480
Average Daily Capital Traded
9,08%
EPS & Dividend